Alivus Life

47
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
871.85
-8.5 (-0.97%)
BSENSE

Jan 19

BSE+NSE Vol: 67.03 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 4.54% vs 5.64% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 1.24% vs 4.97% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 56.14% vs 182.63% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 3.13% vs 0.84% in Mar 2024

Compare Profit and Loss Results of Alivus Life
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,386.00
1,073.00
1,313.00
122.37%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,386.00
1,073.00
1,313.00
122.37%
Expenditure (Ex Depriciation)
Stock Adjustments
27.00
-10.00
37.00
370.00%
Raw Materials Consumed
1,053.00
359.00
694.00
193.31%
Power & Fuel Cost
117.00
20.00
97.00
485.00%
Employee Cost
251.00
127.00
124.00
97.64%
Operating Expenses
134.00
48.00
86.00
179.17%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
53.00
92.00
-39.00
-42.39%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
36.00
7.00
29.00
414.29%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,704.00
803.00
901.00
112.20%
Operating Profit (PBDIT) excl Other Income
682.00
269.00
413.00
153.53%
Other Income
34.00
19.00
15.00
78.95%
Operating Profit (PBDIT)
717.00
289.00
428.00
148.10%
Interest
2.00
34.00
-32.00
-94.12%
Profit before Depriciation and Tax
714.00
255.00
459.00
180.00%
Depreciation
60.00
32.00
28.00
87.50%
Profit Before Taxation & Exceptional Items
654.00
223.00
431.00
193.27%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
654.00
223.00
431.00
193.27%
Provision for Tax
168.00
55.00
113.00
205.45%
Profit After Tax
485.00
167.00
318.00
190.42%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,291.00
199.00
1,092.00
548.74%
Profit Available for appropriations
1,777.00
366.00
1,411.00
385.52%
Appropriations
1,777.00
366.00
1,411.00
385.52%
Equity Dividend (%)
250%
2%
248.00
Earnings Per Share
39.63
11
28.63
260.27%
Profit And Loss - Net Sales
Net Sales 2,386.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.54% vs 5.64% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 682.58 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1.24% vs 4.97% in Mar 2024

Profit And Loss - Interest
Interest 2.41 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 56.14% vs 182.63% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 485.63 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 3.13% vs 0.84% in Mar 2024